Women’s health clinical trials: breaking down barriers through decentralisation
Patient recruitment is one of the most challenging aspects of running clinical trials. Certain socioeconomic factors, such as the disproportionate…
All articles by Kezia Parkins
Kezia Parkins
Kezia Parkins is the lead editor for Medical Device Network and Medical Technology Magazine. She is an experienced healthcare writer and editor with special interests in MedTech, clinical trials, patient centricity and global health equality.
-
-
Revealed: the pharma companies best equipped with AI
The pharmaceutical industry is not only starting to take notice of artificial intelligence (AI), but many companies have started to…
-
2022 forecast: decentralised trials to reach new heights with 28% jump
Projected 28% Growth for Decentralized Trials in 2022 Need to know: A record number of around 1,300 trials with a…
-
Roundtable: the future of AI in clinical research
Artificial Intelligence (AI) is quickly weaving itself into the fabric of our lives across all industries. The life sciences have…
-
Innovation Fund Denmark: attracting investment in clinical trials
Innovation Fund Denmark (IFD) is a public grant agency that part funds entrepreneurs, students and companies to make new products…
-
Telling the story: art’s potential to boost trial diversity
The matter of trial diversity has become a prominent and much talked about topic in clinical research circles. After decades…
-
Trial endpoints: is it time to get selective on surrogates?
The use of surrogate endpoints in clinical research is becoming increasingly common as a way to accelerate getting drugs to…
-
How ketamine trials are providing a blueprint for suicidal ideation research
There are currently no good treatments for people thinking about ending their lives. The World Health Organization recently estimated that,…
-
Impressive early results for Vertex’s potentially curative stem cell diabetes therapy
Vertex's Stem Cell Therapy for Diabetes Cure On Monday, Vertex Pharmaceuticals announced that the first Type 1 diabetes (T1D) patient…
-
Remote communities of healthcare professionals are enabling DCTs
The healthcare industry’s spur to innovate in response to the Covid-19 pandemic has been both impressive and necessary. Perhaps one…